Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -6.80% | 149.19 | 0.0% | $1383.97m | |
| NVAX | Novavax, Inc. | -11.71% | 74.74 | 78.2% | $513.10m | |
| AMGN | Amgen, Inc. | -2.51% | 222.00 | 1.4% | $499.88m | |
| BIIB | Biogen, Inc. | -0.16% | 220.17 | 1.8% | $495.99m | |
| GILD | Gilead Sciences, Inc. | -1.49% | 67.49 | 1.0% | $484.70m | |
| BNTX | BioNTech SE | -1.06% | 145.93 | 0.0% | $409.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.85% | 609.90 | 2.7% | $395.28m | |
| ILMN | Illumina, Inc. | -2.94% | 355.18 | 3.3% | $367.71m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.07% | 225.65 | 1.9% | $337.32m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 2.65 | 0.7% | $185.24m | |
| EXAS | EXACT Sciences Corp. | -2.55% | 72.14 | 17.9% | $164.35m | |
| ARNA | Arena Pharmaceuticals, Inc. | -0.54% | 89.99 | 13.7% | $130.66m | |
| INCY | Incyte Corp. | -0.94% | 74.09 | 2.4% | $128.96m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.99% | 133.69 | 8.2% | $122.51m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.51% | 84.22 | 4.2% | $102.65m |
Company Profile
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.